Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 12, 2018 10:07 ET | Source: Silence Therapeutics plc

US Patent Trial & Appeal Board (PTAB) Upholds Silence Patent by Denying First of Five Patent Grant Review Applications Filed by Alnylam

LONDON, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Silence Therapeutics plc, (AIM:SLN) (“Silence” or “the Company”) a leader in the discovery, development and delivery of novel RNA therapeutics for the...
October 12, 2018 10:05 ET | Source: Silence Therapeutics plc

Silence Therapeutics Announces Receipt of a New European Notice of Intention to Grant a Patent and the Launch of an Interim European Injunction Application against Onpattro™

LONDON, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Silence Therapeutics plc, (AIM:SLN) (“Silence” or “the Company”) a leader in the discovery, development and delivery of novel RNA therapeutics for the...
September 26, 2018 02:00 ET | Source: Silence Therapeutics plc

Silence Therapeutics to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference

LONDON, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Silence Therapeutics plc, (AIM:SLN) (“Silence” or “the Company”) a leader in the discovery, delivery, and development of novel RNA therapeutics for the...
August 07, 2018 02:00 ET | Source: Silence Therapeutics plc

Silence Therapeutics litigation: patisiran EU marketing authorisation imminent

LONDON, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Silence Therapeutics plc, (AIM:SLN) (“Silence” or “the Company”) a leader in the discovery and development of novel RNA therapeutics, announces today an...

keyboard_arrow_left Previous Page